Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 26.70
-0.20 (-0.74%)
At close: Jan 30, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 21.63 billion as of January 30, 2026. Its market cap has increased by 100.81% in one year.
Market Cap
21.63B
Enterprise Value
16.58B
Revenue
1.78B
Ranking
n/a
PE Ratio
61.11
Stock Price
26.70
Market Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 21.63B, an increase of 102.50%. That is a compound annual growth rate of 75.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 21.63B | 48.75% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charoen Pokphand Enterprise (Taiwan) | 43.78B |
| Great Wall Enterprise | 42.59B |
| Lian Hwa Foods | 28.08B |
| Standard Foods | 26.34B |
| TTET Union | 23.36B |
| Microbio | 11.76B |
| Tehmag Foods | 10.34B |
| Ve Wong | 9.35B |